SHARPE
Reported results
- Net sales in Q3 2026 were $544.5 million, an increase of 10% Y/Y compared to $493.8 million in Q3 2025.
- Net income attributable to Quaker Chemical Corporation in Q3 2026 was $30.0 million, or earnings per diluted share of $1.73, compared to $30.5 million, or $1.75 per diluted share in Q3 2025.
- Non-GAAP net income in Q3 2026 was $41.4 million, compared to $36.3 million in Q3 2025.
- Non-GAAP earnings per diluted share in Q3 2026 was $2.39, an increase of 15% Y/Y compared to $2.08 in Q3 2025.
- Adjusted EBITDA in Q3 2026 was $89.8 million, an 8% increase Y/Y compared to $82.9 million in Q3 2025.
Notes
Certain prior period non-GAAP financial measures have been adjusted to conform with current period presentation.
Price and volatility reaction
The stock moved -4.4% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -0.6 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 157.87 | 2026-10-29 |
| Close after release | 150.95 | 2026-10-30 |
| Realised move | -4.4% | close to close |
| 30d ATM IV change | -0.6 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.